Kneat.com Inc
TSX:KSI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.04
7.16
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Kneat.com Inc
kneat.com, Inc. engages in the design, development, and supply of software for data and document management. The company is headquartered in Limerick, Limerick and currently employs 165 full-time employees. The company went IPO on 2014-03-17. The firm's focus is to service the facilities, equipment and computer systems validation (CSV) market within the global life sciences industry. The firm designs develops and supplies software for data and document management within regulated environments. Its product, Kneat Gx, is a configurable, off-the-shelf application focused on validation lifecycle management and testing within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become compliant with an automated process. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, among others.
kneat.com, Inc. engages in the design, development, and supply of software for data and document management. The company is headquartered in Limerick, Limerick and currently employs 165 full-time employees. The company went IPO on 2014-03-17. The firm's focus is to service the facilities, equipment and computer systems validation (CSV) market within the global life sciences industry. The firm designs develops and supplies software for data and document management within regulated environments. Its product, Kneat Gx, is a configurable, off-the-shelf application focused on validation lifecycle management and testing within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become compliant with an automated process. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, among others.
SaaS Growth: SaaS revenue grew 33% year-over-year in Q3, outpacing industry averages and highlighting ongoing demand despite macro uncertainty.
Revenue & ARR: Total revenue for the quarter rose 26% to $16.1 million, with annual recurring revenue (ARR) up 37% to $68.6 million.
Profitability: Gross profit increased 25% year-over-year, though gross margin slipped slightly to 76% from 77% last year.
Operating Expenses: Operating expenses climbed 43% due to higher investment in R&D and sales and marketing.
Macroeconomic Impact: Management noted some deal slippage and extended buying cycles from budget uncertainty and trade issues, but the pipeline remains robust.
Competition: Increased competition from entrants like Veeva is noted, but Kneat continues to win key deals and maintain a strong product edge.
AI & Product Innovation: Ongoing investment in AI and agile platform capabilities is aimed at widening Kneat’s competitive advantage.
Guidance: Management targets typical SaaS profitability margins (late 20s to early 30s percent) over the next 18 months and remains focused on achieving cash flow breakeven in 2026.
